- Home
- GROW vs CCEL Comparison
GROW vs CCEL Comparison
Compare GROW & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GROW | CCEL |
|---|---|---|
| Founded | 1968 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Managed Health Care |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.2M | 32.7M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | GROW | CCEL |
|---|---|---|
| Price | $2.49 | $3.61 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 34.4K | 11.8K |
| Earning Date | 02-11-2026 | 02-27-2026 |
| Dividend Yield | 3.67% | ★ 11.30% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | $8,546,000.00 | ★ $31,747,500.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $37.57 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.02 | $3.19 |
| 52 Week High | $2.78 | $8.79 |
Technical Indicators
Market Signals| Indicator | GROW | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 55.29 | 41.77 |
| Support Level | $2.45 | $3.49 |
| Resistance Level | $2.55 | $4.14 |
| Average True Range (ATR) | 0.07 | 0.29 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 64.86 | 35.78 |
Price Performance
Historical ComparisonAbout GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.